Register to get unlimited access to all of Citywire’s fund manager database. Registration is free and only takes a minute.

CF Woodford Equity Income A Sterling Acc

Ranked 96 out of 108 in - UK Equity Income over 12 months
All calculations are in USD unless stated

Managed by

Neil Woodford

Neil Woodford remains one of the best known and best performing fund managers in the UK market today. His large bets in the more defensive tobacco and utilities sectors, coupled with his dislike for the banking sector cost him during the stockmarket’s rally in spring 2003. However, Woodford characteristically bounced back, quite in keeping with his emphasis on investing for the long term, regardless of short-term sentiment. As head of investments at Invesco Perpetual Woodford controlled over £15 billion of assets, and spent 26 years at the company before leaving in 2014 to set up his own fund management firm, Woodford Investment Management LLP. He has a degree in economics from Exeter University and in 2013 was awarded a CBE for services to the economy.


The Fund aims to provide investors with long-term appreciation by investing in stocks primarily listed on the UK stock exchanges and to achieve income of 10% higher than the FTSE All Share Index yield.

Showing fund performance globally. You can view performance in individual jurisdictions.


UK Equity Income over : 31/07/2016 - 31/07/2017
  • Rank 96/108 Total Return
  • Rank 69/108 Standard Deviation
  • Rank 93/108 Max Drawdown
Fund Name Currency Return
94 RWC Enhanced Income B GBP

Currency exposure is hedged

Currency exposure is hedged



94 Old Mutual WoodFord Equity Income A GBP Acc USD


96 CF Woodford Equity Income A Sterling Acc USD


97 Fidelity MoneyBuilder Dividend A Inc USD


98 Trojan Income O Acc USD


Total Return

Quarterly Performance

to 30/06/2017 Annual Q1 Q2 Q3 Q4
2017 5.9% 6.5%
2016 -13.5% -6.4% -7.3% 5.5% -5.5%
2015 9.9% 3.4% 5.8% -3.1% 3.7%
2014 -1.5% -0.4%

Month by Month Performance

Returns Vs Risk

Asset Allocation



Top 10 Holdings

Stock Size
AstraZeneca PLC ORD 8.53
Imperial Brands PLC ORD 7.52
GlaxoSmithKline PLC ORD 6.54
British American Tobacco PLC ORD 6.51
Legal & General Group PLC ORD 5.23
Provident Financial PLC ORD 4.93
Prothena Corporation PLC ORD 3.34
AbbVie Inc ORD 3.18
Theravance Biopharma Inc ORD 2.34
Capita PLC ORD 2.25

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date02/06/2014
  • Share Class size73Mn
  • Base currencyGBP

Purchase Info

  • Min. initial investment150,000
  • Min. regular additional investment0


  • Annual management1.00%
  • Initial investment0

Related News

The Secret CEO: why I let an outperforming manager go

In response to our Secret CIO's columns describing the good, the bad and the ugly of fund management, our Secret CEO recalls their experiences.

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in USD).